Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
1
Filings (14d)
Data as of 2026-07-07
2026-07-07
Privia Health Group director Shawn Morris resigned from the board and the Compliance Committee effective July 6, 2026. The company stated the departure was not due to any disagreement over operations, policies, or practices, and thanked him for his service.
Who are the top institutional investors holding PRIVIA HEALTH GROUP INC (PRVA)?
Major stakeholders currently include BlackRock, Inc. ($392.0M), FMR LLC ($268.3M), Durable Capital Partners LP ($248.6M). Based on the latest 13F filings, there are a total of 290 tracked investment funds and institutions maintaining positions in PRVA.
What is the overall institutional sentiment toward PRVA recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $375.3M, driven by 146 managers accumulating shares while 132 reduced their exposure.
Which institutions have been selling or reducing their PRVA positions?
In the latest period, 99 funds trimmed their holdings, and 33 managers completely exited their positions. The aggregate reported sell value was $821.5M.
Are there any notable investors adding PRVA to their portfolios?
Yes, buying activity remains notable. 45 institutions opened new positions in {ticker}, and 101 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.4B.
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter